Estats Units - anglès - NLM (National Library of Medicine)

american regent, inc. - dopamine hydrochloride (unii: 7l3e358n9l) (dopamine - unii:vtd58h1z2x) - dopamine hydrochloride 160 mg in 1 ml

Estats Units - anglès - NLM (National Library of Medicine)

american regent, inc. - levetiracetam (unii: 44yrr34555) (levetiracetam - unii:44yrr34555) - levetiracetam 100 mg in 1 ml

Estats Units - anglès - NLM (National Library of Medicine)

american regent, inc. - calcitriol (unii: fxc9231jvh) (calcitriol - unii:fxc9231jvh) - calcitriol 1 ug in 1 ml

Estats Units - anglès - NLM (National Library of Medicine)

american regent, inc. - pamidronate disodium (unii: 8742t8zqza) (pamidronic acid - unii:oyy3447omc) - pamidronate disodium 3 mg in 1 ml

Estats Units - anglès - NLM (National Library of Medicine)

american regent, inc. - esmolol hydrochloride (unii: v05260lc8d) (esmolol - unii:mdy902uxsr) - esmolol hydrochloride 10 mg in 1 ml

Estats Units - anglès - NLM (National Library of Medicine)

american regent, inc. - metoprolol tartrate (unii: w5s57y3a5l) (metoprolol - unii:geb06nhm23) - metoprolol tartrate 1 mg in 1 ml

Estats Units - anglès - NLM (National Library of Medicine)

american regent, inc. - etomidate (unii: z22628b598) (etomidate - unii:z22628b598) - etomidate 2 mg in 1 ml

Estats Units - anglès - NLM (National Library of Medicine)

american regent, inc. - clonidine hydrochloride (unii: w76i6xxf06) (clonidine - unii:mn3l5rmn02) - clonidine hydrochloride 100 ug in 1 ml

Estats Units - anglès - NLM (National Library of Medicine)

american regent, inc. - methyldopate hydrochloride (unii: 7px435dn5a) (methyldopa anhydrous - unii:m4r0h12f6m) - methyldopate hydrochloride 50 mg in 1 ml

Estats Units - anglès - NLM (National Library of Medicine)

american regent, inc. - estradiol valerate (unii: okg364o896) (estradiol - unii:4ti98z838e) - estradiol valerate injection is indicated in the: 1.    treatment of moderate to severe vasomotor symptoms associated with the menopause. 2.    treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause.  when prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered. 3.    treatment of hypoestrogenism due to hypogonadism, castration or primary ovarian failure. 4.    treatment of advanced androgen-dependent carcinoma of the prostate (for palliation only). estradiol valerate injection should not be used in women with any of the following conditions: 1.    undiagnosed abnormal genital bleeding. 2.    known, suspected, or history of cancer of the breast. 3.    known or suspected estrogen-dependent neoplasia. 4.    active deep vein thrombosis, pulmonary embolism or a history of these conditions. 5.    active or recent (e.g., within the past year) arterial thromboembolic disease (e.g., stroke, myocardial i